ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
202 hedge funds and large institutions have $2.57B invested in Intercept Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 86 increasing their positions, 43 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
48% less call options, than puts
Call options by funds: $237M | Put options by funds: $460M
Holders
202
Holding in Top 10
4
Calls
$237M
Puts
$460M
Top Buyers
| 1 | +$74.1M | |
| 2 | +$63.5M | |
| 3 | +$59.2M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$41.1M |
| 5 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$29.8M |
Top Sellers
| 1 | -$60.5M | |
| 2 | -$55.4M | |
| 3 | -$28.8M | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$24.1M |
| 5 |
D.E. Shaw & Co
New York
|
-$21.4M |